MTHFR gene variants do not directly block iron absorption in the gut. There is no established biochemical pathway where the MTHFR enzyme controls how iron crosses the intestinal lining or enters the bloodstream. However, MTHFR variants can indirectly affect your iron status in several meaningful ways, primarily through their impact on folate metabolism, red blood cell production, and vitamin B12 activity.
How MTHFR Connects to Iron Indirectly
The MTHFR enzyme converts folate into its active form, methylfolate, which your body needs for the methylation cycle. This cycle is essential for DNA synthesis, cell division, and the production of red blood cells. When MTHFR variants (most commonly C677T and A1298C) reduce the enzyme’s efficiency, the downstream effects can ripple into iron metabolism without ever touching iron absorption itself.
One key connection is through vitamin B12. The folate and B12 pathways are tightly linked. Low vitamin B12 levels are associated with reduced iron uptake, partly because B12 deficiency can cause inflammation and damage to the stomach lining, including the glands that produce intrinsic factor. This creates a cascading problem: impaired MTHFR function can disrupt folate processing, which strains the B12-dependent methylation pathway, which in turn can compromise the conditions your stomach needs to handle iron efficiently.
Iron deficiency is also linked to elevated homocysteine, an amino acid that builds up when the methylation cycle stalls. High homocysteine is a recognized marker of B vitamin deficiencies and chronic inflammation, both of which can worsen iron status over time. If you carry an MTHFR variant that raises your homocysteine levels, you may be more vulnerable to this inflammatory loop.
The Role of Methylation in Red Blood Cell Production
Your body produces roughly 200 billion red blood cells every day, and each one requires iron to carry oxygen. But making those cells also depends on proper DNA methylation, the process of adding chemical tags to DNA that control which genes turn on and off during cell development. This is where MTHFR’s role becomes relevant to how your body uses iron, even if it doesn’t affect absorption at the gut level.
Red blood cell production (erythropoiesis) requires a dynamic balance of DNA methylation and demethylation at every stage. During early development, methylation keeps the cell cycle running on schedule by silencing genes that would otherwise halt cell division too soon. During the final maturation stage, methylation stabilizes protein production inside the cell and prevents a type of cellular stress that triggers premature cell death. When methylation is disrupted, red blood cell precursors can stall, die off, or fail to mature properly.
Because MTHFR variants reduce the supply of methylfolate, the primary methyl donor feeding this entire system, they can compromise red blood cell production at a fundamental level. The result may not look like a straightforward iron deficiency on a blood test, but it can produce similar symptoms: fatigue, weakness, brain fog, and pallor.
Why Anemia Can Be Tricky to Diagnose
One of the most practical things to understand about MTHFR and iron is that the two can create overlapping types of anemia that mask each other on standard lab work. Folate or B12 deficiency typically causes megaloblastic anemia, where red blood cells grow abnormally large. Iron deficiency causes microcytic anemia, where red blood cells are abnormally small. When both problems exist at the same time, the large and small cells can average out to a normal mean cell volume (MCV) on a complete blood count, making it look like nothing is wrong.
The clue in this situation is the red cell distribution width (RDW), which measures how much variation exists in the size of your red blood cells. A normal MCV paired with an elevated RDW suggests two competing types of anemia are present simultaneously. This combination is worth flagging to your healthcare provider if you know you carry an MTHFR variant and have persistent fatigue or other anemia symptoms that don’t match your lab results.
Supplementing Folate Can Deplete Iron
Here’s a detail that catches many people off guard: correcting a folate or B12 deficiency can actually trigger iron deficiency. When you start supplementing with either nutrient, bone marrow responds rapidly by ramping up red blood cell production. That sudden surge in new red blood cells draws heavily on your iron stores. If your iron was borderline before supplementation, it can tip into outright deficiency within weeks.
This is especially relevant for people with MTHFR variants who begin taking methylfolate for the first time. The boost in available folate can kickstart a production line that your iron reserves aren’t prepared to support. Monitoring ferritin levels (a measure of stored iron) during the early weeks of folate supplementation helps catch this before symptoms develop.
What This Means in Practice
If you carry an MTHFR variant and struggle with low iron or persistent anemia, the explanation probably isn’t that your body can’t absorb iron from food or supplements. The more likely scenarios are that impaired folate metabolism is undermining red blood cell production, that elevated homocysteine is driving low-grade inflammation affecting iron status, or that concurrent nutrient deficiencies are creating a mixed picture that standard blood tests don’t easily reveal.
The nutrients involved in this system, folate, B12, iron, and zinc, function as a team. A bottleneck in one creates pressure on the others. For people with reduced MTHFR function, supporting the entire chain rather than focusing on iron alone tends to produce better results. Active methylfolate rather than synthetic folic acid is the relevant form for those with significant MTHFR variants, since the enzyme that converts folic acid to its usable form is the exact enzyme that’s compromised.